Wall Street Analysts See a 48.15% Upside in Xenon Pharmaceuticals (XENE): Can the Stock Really Move This High?

Xenon Pharmaceuticals (XENE) closed the last trading session at $38.28, gaining 30.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 56.71 indicates a 48.2% upside potential.The average comprises 14 short-term price targets ranging from a low of $42 to a high of$ 65, with a standard deviation of $6.73. While the lowest estimate indicates an increase of 9.7% from the current price ...